Journal of Shandong University (Health Sciences) ›› 2021, Vol. 59 ›› Issue (11): 48-52.doi: 10.6040/j.issn.1671-7554.0.2021.0795
Previous Articles Next Articles
LIANG Tingting, YANG Yongxia, HOU Congzhe, HUANG Taisheng, WANG Huali, ZHU Lin
CLC Number:
| [1] Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries [J]. CA Cancer J Clin, 2018, 68(6): 394-424. [2] zur Hausen H. Papillomaviruses and cancer: from basic studies to clinical application [J]. Nat Rev Cancer, 2002, 2(5): 342-350. [3] MacLaughlin KL, Jacobson RM, Radecki BC, et al. Trends over time in pap and pap-HPV cotesting for cervical cancer screening[J]. J Womens Health(Larchmt). 2019,28(2):244-249. [4] Nkwabong E, Laure Bessi Badjan I, Sando Z.Pap smear accuracy for the diagnosis of cervical precancerous lesions [J]. Trop Doct, 2019, 49(1): 34-39. [5] Narkcham S, Mody DR, Jones A, et al. Rescreening of high-risk HPV positive Papanicolaou tests initially screened as negative is a low yield procedure in the era of HPV genotyping [J]. J Am Soc Cytopathol, 2021, 19: S2213-2945. doi: 10.1016/j.jasc.2021.05.002. [6] Er Güneri S, ?瘙塁en S. Womens experiences after abnormal Pap smear results: a qualitative study [J]. J Psychosom Obstet Gynaecol, 2020, 41(1): 22-29. [7] Hoda RS, Finer EB, Arpin RN, et al. Risk of malignancy in the categories of the Papanicolaou Society of Cytopathology system for reporting pancreaticobiliary cytology [J]. J Am Soc Cytopathol, 2019, 8(3): 120-127. [8] Bhatla N, Singhal S. Primary HPV screening for cervical cancer [J]. Best Pract Res Clin Obstet Gynaecol, 2020, 65: 98-108. doi: 10.1016/j.bpobgyn.2020.02.008. [9] Pista A, Costa C, Saldanha C, et al. Budget impact analysis of cervical cancer screening in Portugal: comparison of cytology and primary HPV screening strategies [J]. BMC Public Health, 2019, 19(1): 235. doi: 10.1186/s12889-019-6536-4. [10] Zhang Y, Wang J, Zhang R, et al. Application value of detection of high-risk HPV infection in early cervical cancer patients in disease diagnosis and prognosis evaluation [J]. Clin Lab, 2020, 66(12). doi: 10.7754/Clin.Lab.2020.200245. [11] Pruski D, Millert-Kalinska S, Lewek A, et al. Sensitivity and specificity of HR HPV E6/E7 mRNA test in detecting cervical squamous intraepithelial lesion and cervical cancer [J]. BMC Cancer, 2019, 90(2):66-71. [12] Xu G, Liu Y, Zhang C, et al. Temporal and spatial expression of Sox9, Pax1, TGF-β1 and type Ⅰ and Ⅱ collagen in human intervertebral disc development [J]. Neurochirurgie, 2020, 66(3): 168-173. [13] El Aliani A, El-Abid H, El Mallali Y, et al. Association between gene promoter methylation and cervical cancer development: global distribution and a meta-analysis [J]. Cancer Epidemiol Biomarkers Prev, 2021, 30(3): 450-459. [14] Kelly H, Benavente Y, Pavon MA, et al. Performance of DNA methylation assays for detection of high-grade cervical intraepithelial neoplasia(CIN2+): a systematic review and meta-analysis [J]. Bri J Cancer, 2019, 121(11): 954-965. [15] Fang C, Wang SY, Liou YL, et al. The promising role of PAX1(aliases: HUP48, OFC2)gene methylation in cancer screening [J]. Mol Genet Genomic Med, 2019, 7(3): e506. doi: 10.1002/mgg3.506. [16] 李明珠, 魏丽惠. 甲基化检测在宫颈癌诊治中的意义[J].现代妇产科进展,2019, 28(9): 704-705. LI Mingzhu, WEI Lihui. Significance of methylation detection in the diagnosis and treatment of cervical cancer [J]. Progress in Obstetrics and Gynecology, 2019, 28(9): 704-705. [17] Li B, Guo R, Lai T, et al. The application of PAX1 methylation detection and HPV E6/E7 mRNA detection in cervical cancer screening [J]. J Obstet Gynaecol Res, 2021, 47(8): 2720-2728. [18] Dvorská D, Brany D, Nagy B, et al. Aberrant methylation status of tumour suppressor genes in ovarian cancer tissue and paired plasma samples [J]. Int J Mol Sci, 2019, 20(17): 4119. doi: 10.3390/ijms20174119. [19] Liu H, Meng X, Wang J. Real time quantitative methylation detection of PAX1 gene in cervical cancer screening [J]. Int J Gynecol Cancer, 2020, 30(10): 1488-1492. [20] Wang M, Hou B, Wang X, et al. Diagnostic value of high-risk human papillomavirus viral load on cervical lesion assessment and ASCUS triage [J]. Cancer Med, 2021, 10(7): 2482-2488. [21] Oranratanaphan S, Kobwitaya K, Termrungruanglert W, et al. Value of CCNA1 promoter methylation in triaging ASC-US cytology [J]. Asian Pac J Cancer Prev, 2020, 21(2): 473-477. [22] Curry SJ, Krist AH, Owens DK, et al. Screening for cervical cancer: us preventive services task force recommendation statement [J]. JAMA, 2018, 320(7): 674-686. [23] Sammarco ML, Tamburro M, Pulliero A, et al. Human papillomavirus infections, cervical cancer and microRNAs: an overview and implications for public health [J]. Microrna, 2020, 9(3): 174-186. [24] Gutnik H, Kastelic P, Oštrbenk Valen cak A, et al. Histomorphologic assessment and distribution of high-risk human papillomavirus(HPV)types in cervical high-grade squamous intraepithelial lesions with unusual histomorphologic features [J]. Virchows Arch, 2020, 476(2): 251-260. [25] Torres-Poveda K, Ruiz-Fraga I, Madrid-Marina V, et al. High risk HPV infection prevalence and associated cofactors: a population-based study in female ISSSTE beneficiaries attending the HPV screening and early detection of cervical cancer program [J]. BMC Cancer, 2019, 19(1): 1205. doi: 10.1186/s12885-019-6388-4. [26] 王文杰, 余敏红, 范世珍, 等. 人乳头瘤病毒(HPV)型别与SOX1和PAX1基因甲基化的相关性研究[J]. 中国实验诊断学, 2020, 24(8): 1353-1356. WANG Wenjie, YU Minhong, FAN Shizhen, et al. A correlation between human papillomavirus(HPV)type and methylation of SOX1 and PAX1 genes [J]. Chinese Journal Laboratory Diagnosis, 2020, 4(8): 1353-1356. |
| [1] | XIU Dejian, GAO Zhengwen, SONG Tingting, CUI Nan, CUI Jing, SUN Jianping. Genes associated with cervical cancer by integrated bioinformatics analysis [J]. Journal of Shandong University (Health Sciences), 2022, 60(10): 99-109. |
| [2] | CHEN Quancai, HAN Sai, LIU Lu, SUN Yu, YOU Xuewu, ZHANG Junhua, ZHANG Youzhong. Expressions and significance of CDC7 and MCM4 in 105 cases of cervical lesions [J]. Journal of Shandong University (Health Sciences), 2022, 60(1): 34-39. |
| [3] | ZHOU Huimei, YANG Jiaxin, CAO Dongyan, SHEN Keng, XIANG Yang, WU Ming, PAN Lingya, HUANG Huifang, LANG Jinghe. Fertility-sparing radical trachelectomy for young women with early stage cervical cancer: surgical and obstetrical outcomes [J]. Journal of Shandong University (Health Sciences), 2018, 56(5): 18-22. |
| [4] | YANG Jiaxin, SHEN Keng, WANG Yao. Status and prospect of fertility preservation treatment for gynecologic malignancies [J]. Journal of Shandong University (Health Sciences), 2018, 56(5): 1-7. |
| [5] | CHEN Ying, ZHOU Xiaoqing, QI Mei, ZHANG Weifang, LIU Juan, ZHAO Weiming. Effects of PRPS2 knockdown on the biological property of cervical cancer cells [J]. Journal of Shandong University (Health Sciences), 2018, 56(2): 9-13. |
| [6] | WANG Yong, JIANG Chen, ZHOU Shiying, YANG Xiaomei. Effect of IQ motif-containing GTPase activating protein 3 on the proliferation and migration of cervical cancer cells [J]. Journal of Shandong University (Health Sciences), 2018, 56(10): 103-109. |
| [7] | LIU Jingkang, YANG Jianyong, MENG Lihua, JIANG Jie. The value of serum miR-17-92 cluster in early diagnosis of HPV-positive cervical cancer [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2017, 55(5): 86-90. |
| [8] | SUN Zeyu, CHEN Ying, LIN Jiaxiang, LIU Juan, ZHAO Weiming. Influence of inositol polyphosphate-4-phosphatase type II on the proliferation and apoptosis of cervical cancer cells [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2017, 55(11): 1-6. |
| [9] | WANG Yao, CUI Guoying, WANG Fei, LI Changzhong. Expression and significance of human leucocyte antigen-E in cervical cancer [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2016, 54(9): 59-63. |
| [10] | WANG Yafen, YANG Yongxia, LIU Ya, MA Demei, ZHU Lin. Use of Cervista HPV HR A9 group virus to identify patients with negative cytological but positive high-risk HPV [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2016, 54(8): 69-71. |
| [11] | PENG Hui, HE Junmei, SU Xuelian. Expression of serum miR-375 and its clinical significance in the diagnosis and postoperative monitoring of cervical cancer [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2016, 54(3): 68-71. |
| [12] | YUAN Shoudao, WANG Fengqin, ZHANG Jiao, ZHAO Weiming, Jason J. Chen. Mass spectrometry analysis of proteins differentially expressed between adenocarcinoma and squamous carcinoma of the cervix [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2014, 52(8): 14-21. |
| [13] | ZHANG Yanliang1, ZHUANG Zirong2, ZHU Lin1, LIANG Tingting1 . Quality of life after laparoscopic surgery for cervical cancer patients [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2014, 52(6): 62-66. |
| [14] | ZHANG Wen1, FENG Tingting1, ZHENG Lin1, WANG Hong1, LU Yi2, QI Mei1, YU Xiuping1, TANG Wei1, ZHAO Weiming1. Effects of enhanced expression of RbAp48 mediated by recombinant adenovirus on proliferation and growth of cervical cancer cells [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2014, 52(4): 13-17. |
| [15] |
LIU Jian-meng， CUI Bao-xia， YIN Ting， ZHANG Ai-rong.
Expression and significance of pigment epithelium-derived factor in cervix squamous cell carcinoma [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2012, 50(5): 103-106. |
|
